COMMUNIQUÉS West-GlobeNewswire

Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
26/08/2025
- Presentations Highlight the Versatility of Clearside’s SCS Microinjector ® Platform for the Treatment of Multiple Retinal Diseases - - CLS-AX Trial Designs in Wet AMD and Diabetic Retinopathy to be Featured in [...]
Adagene to Participate in Two Investor Conferences in September
26/08/2025
SAN DIEGO and SUZHOU, China, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today [...]
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
26/08/2025
Using AI, CDT Equity Inc. identifies a novel therapeutic indication for its lead programmes, supported by successful pre-clinical trial data NAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 26, 2025 (GLOBE NEWSWIRE) -- [...]
Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
26/08/2025
Company to Advance Development of its Patented Device LAS VEGAS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY ) (the “Company” or “Odyssey”), a technology and asset acquisition company focused on [...]
PolarityBio Completes Enrollment in the Phase III Pivotal Study of SkinTE for Diabetic Foot Ulcers
26/08/2025
SALT LAKE CITY, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PolarityBio , a clinical-stage biotechnology company focused on addressing unmet needs in wound healing through innovation in autologous regenerative skin multicellular [...]
Dr. Shai Efrati Honored With 2025 Ellis Island Medal of Honor
26/08/2025
Hyperbaric oxygen therapy pioneer and Aviv Clinics medical advisor honored for research and service to veterans and patients with stroke, PTSD, long COVID and more THE VILLAGES, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- [...]
FAMU College of Pharmacy Alumnus and Industry Pioneer Stan Loomis Inducted into Gallery of Distinction and Keynoted the 2025 White Coat Ceremony
26/08/2025
Pharmacy Leader and FAMU Alumnus Stan Loomis Received Top Honor, Inspire Future Pharmacists as Keynote Speaker ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olympia and Wesley Pharmaceuticals , two of the nation's [...]
Omada Health to Participate in Upcoming Investor Conference
26/08/2025
SAN FRANCISCO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the Morgan Stanley 23rd [...]
Fifty1 Labs Partners with LUNR Aerospace to Pioneer AI-Driven Drug Repurposing for Space Medicine, Strategic Collaboration Aims to Harness AI and Orbital Access to Revolutionize Astronaut Health Solutions in a $2 Billion Market by 2032
26/08/2025
VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. ( OTC: FITY ), has entered a groundbreaking partnership with LUNR Aerospace to develop AI- [...]
The Hemp Doctor’s Kayo Line Delivers a Sweet Knockout with New Delta 9 Krispy Bites
26/08/2025
MOORESVILLE, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor adds the latest contender to its high-potency edible Kayo line: the Kayo Delta 9 Krispy Bites . Packed with nostalgia, flavor, and a knockout dose of [...]
Genmab to Participate in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference
26/08/2025
Media Release COPENHAGEN, Denmark; August 26, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its Chief Executive Officer Jan Van de Winkel and C hief F inancial O fficer Anthony Pagano will participate in a [...]
Circurna Engages GATC Health for AI-Powered Discovery to Accelerate ciRNA™ Circular RNA Therapeutics
26/08/2025
AI-driven discovery aims to speed development, improve delivery precision, and expand therapeutic potential of Circurna’s ciRNA™ circular RNA platform HOUSTON and IRVINE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- [...]
Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis
26/08/2025
VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered [...]
Life Biosciences Presents New Data at ARDD 2025 on the Company’s Partial Epigenetic Reprogramming Platform in Liver and Ocular Diseases
26/08/2025
ER-300 improves key biomarkers of liver health in an animal model of MASH These data, along with additional ER-100 preclinical data from a nonhuman primate model of NAION demonstrating clear restoration of methylation [...]
Er-Kim Announces Exclusive Agreement with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey
26/08/2025
Partnership will broaden portfolio distribution of oncology products to cancer patients in the specified regions WARSAW, Poland and LONDON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Er-Kim , an international pharmaceutical [...]
Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparedness
26/08/2025
Funding to accelerate development of Osivax’ broad-spectrum influenza A vaccine candidate, OVX836 Lyon, France and Liège, Belgium – August 26, 2025 – Osivax , a biopharmaceutical company developing vaccines to provide [...]
Scenic Enters License and Research Agreement with Alnylam
26/08/2025
Amsterdam, the Netherlands, August 26, 2025 – Scenic Biotech , a pioneer in modifier therapies for severe diseases, today announced a license and research agreement with Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) to [...]
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
26/08/2025
WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23 rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on [...]
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
26/08/2025
— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease — — Pro forma [...]

Pages